These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34651755)

  • 1. Cognitive Dysfunction in Cats: Update on Neuropathological and Behavioural Changes Plus Clinical Management.
    Sordo L; Gunn-Moore DA
    Vet Rec; 2021 Jan; 188(1):e3. PubMed ID: 34651755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of Aging in Cats and its Similarities to Human Alzheimer's Disease.
    Sordo L; Martini AC; Houston EF; Head E; Gunn-Moore D
    Front Aging; 2021; 2():684607. PubMed ID: 35822024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction in cats: a syndrome we used to dismiss as 'old age'.
    Landsberg GM; Denenberg S; Araujo JA
    J Feline Med Surg; 2010 Nov; 12(11):837-48. PubMed ID: 20974401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior and Cognition of the Senior Cat and Its Interaction with Physical Disease.
    Denenberg S; Machin KL; Landsberg GM
    Vet Clin North Am Small Anim Pract; 2024 Jan; 54(1):153-168. PubMed ID: 37865588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Causes of Increased Vocalisation in Elderly Cats with Cognitive Dysfunction Syndrome as Assessed by Their Owners.
    Černá P; Gardiner H; Sordo L; Tørnqvist-Johnsen C; Gunn-Moore DA
    Animals (Basel); 2020 Jun; 10(6):. PubMed ID: 32599838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].
    Gertz HJ; Kurz A
    Nervenarzt; 2011 Sep; 82(9):1151-9. PubMed ID: 21221517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive dysfunction in cats: clinical assessment and management.
    Gunn-Moore DA
    Top Companion Anim Med; 2011 Feb; 26(1):17-24. PubMed ID: 21435622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin.
    Spinedi E; Cardinali DP
    Neuroendocrinology; 2019; 108(4):354-364. PubMed ID: 30368508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid Pathologies.
    Deba F; Peterson S; Hamouda AK
    Methods Mol Biol; 2019; 2011():393-412. PubMed ID: 31273712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases.
    Youssef SA; Capucchio MT; Rofina JE; Chambers JK; Uchida K; Nakayama H; Head E
    Vet Pathol; 2016 Mar; 53(2):327-48. PubMed ID: 26869150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
    Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
    Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
    J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid pathology in the progression to mild cognitive impairment.
    Insel PS; Hansson O; Mackin RS; Weiner M; Mattsson N;
    Neurobiol Aging; 2018 Apr; 64():76-84. PubMed ID: 29353101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.